Clinical Trial Update: Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating empagliflozin for heart failure with preserved ejection fraction in a cardiology outpatient setting; currently active and not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Conrado Roberto Hoffmann Filho | Conditions: Congestive Heart Failure (CHF) | Phase 3 | Status: ACTIVE_NOT_RECRUITING